The current PE ratio for Iradimed stock as of May 17, 2024 is 29.6. This is calculated based on the TTM EPS of $1.42 and the stock price of $42.03 per share. The PE ratio marks a decrease of 16% from its last 4 quarters average of 35.4.
The average historical PE ratio of Iradimed for the last ten years is 61.71. The current P/E ratio of 29.6 is 52% lower than the historical average. Looking back at the last ten years, IRMD's PE ratio peaked in the Mar 2021 quarter at 322.13, when the price was $25.77 and the EPS was $0.08. The lowest point was in the Dec 2016 quarter, when it reached 16.32 with a price of $11.1 and an EPS of $0.68.
Maximum annual increase: 1,756.62% in 2017
Maximum annual decrease: -86.32% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 34.9 | 25.81% |
2022 | 27.74 | -54.38% |
2021 | 60.8 | -68% |
2020 | 190 | 590.66% |
2019 | 27.51 | -33.65% |
2018 | 41.46 | -86.32% |
2017 | 303 | 1,756.62% |
2016 | 16.32 | -60.41% |
2015 | 41.22 | -26.51% |
2014 | 56.09 | N/A |
Currently, IRMD's PE ratio is lower than its 3 and 5-year averages.
IRMD's PE ratio stands lower than its peer stocks EW and DXCM.
Stock name | PE ratio | Market cap |
---|---|---|
IRMD Iradimed Corp | 29.6 | $532.28M |
EW Edwards Lifesciences Corp | 38.26 | $53.66B |
COO Cooper Companies Inc | 66.2 | $19.34B |
DXCM Dexcom Inc | 79.61 | $52.24B |
IRMD stock has a price to earnings ratio of 29.6 as of May 17, 2024.
The 3-year average price to earnings ratio for IRMD stock is 44.15.
The 5-year average price to earnings ratio for IRMD stock is 63.02.
Over the last ten years, the Mar 2021 quarter recorded the highest quarterly PE ratio at 322.13.
The current PE ratio of IRMD is 52% lower than the 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (May 17, 2024), Iradimed's share price is $42.03. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.42. Therefore, Iradimed's PE ratio for today is 29.6. PE RATIO(29.6) = STOCK PRICE($42.03) / TTM EPS($1.42)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.